Anthracyclic dilated cardiomyopathy complicated by multiple intracavitary thrombi. Case Report
DOI:
https://doi.org/10.37615/retic.v8n2a13Keywords:
cardiomyopathy, anthracyclics, cardiac thrombusAbstract
Cardiac dysfunction related to chemotherapy is a clinic-pathological entity that represents an important cause of morbidity and mortality in cancer patients. Its incidence is related to risk factors such as age, sex, previous cardiovascular disease, use of anthracyclic agents and cumulative doses of antineoplastics, adjuvant radiotherapy, genetic alterations, etc. Its early identification allows to offer better care aimed at prevention and timely diagnosis as well as monitoring and prognosis. We present the case of a young woman with leukemia who developed heart failure one year after completing chemotherapy with an associated thrombotic complication.
Downloads
Metrics
References
Velásquez CA, González M, Berrouet MC, et al. Cardiotoxicidad inducida por la quimioterapia desde las bases moleculares hasta la perspectiva clínica. Revista Colombiana de Cardiología. marzo de 2016;23(2):104-11. doi: https://doi.org/10.1016/j.rccar.2015.10.002 DOI: https://doi.org/10.1016/j.rccar.2015.10.002
ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal (2022) 43, 4229–4361. doi: https://doi.org/10.1093/eurheartj/ehac244. DOI: https://doi.org/10.1093/eurheartj/ehac244
Saunderson C, Plein S, Mainsty C. Role of cardiovascular magnetic resonance imaging in cardio-oncology. European Heart Journal - Cardiovascular Imaging (2021) 22, 383–396. doi: https://doi.org/10.1093/ehjci/jeaa345 DOI: https://doi.org/10.1093/ehjci/jeaa345
Yoo Jin H, Jinhee K, Kyunghwa H, et al. Chemotherapy-Related Cardiac Dysfunction: Quantitative Cardiac Magnetic Resonance Image Parameters and Their Prognostic Implications. Korean J Radiol 2023;24(9):838-848 doi: https://doi.org/10.3348/kjr.2023.0095 DOI: https://doi.org/10.3348/kjr.2023.0095
Seferović PM, et al. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eur J Heart Fail. 2023 Nov;25(11):1899-1922. doi: https://doi.org/10.1002/ejhf.2979 DOI: https://doi.org/10.1002/ejhf.2979
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jessica Mariel Bazo Medina, Jesús Samuel Borges López, Julio Cesar Alvarado Ávila, Darwin Saul Hernández Pineda, Eduardo Ayala Hernández, Rodolfo de Jesús Castaño Guerra
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
